Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
View from the Thoraxcenter: ESC 25 Late-breaking Science Wrap-Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 7 months ago
Explore ESC 25 Top Trials with Insights from the Thoraxcenter!Join Prof Nicolas Van MieghemandDr Joost Daemen from Erasmus MC, Rotterdam, for an engaging and critical analysis of the latest trials unveiled at ESC 2025.In this comprehensive ESC wrap-up, interventional experts examine the most significant trials, providing valuable insights into their impact on current practices and future research… View more

Intervention

Electrophysiology & Arrhythmia
Pre-implant Right Ventricular dP/dt Can Predict Severe Right Ventricular Failure After Left Ventricular Assist Device Implantation
Author(s): Parth Visrodia , Aniket S Rali , Gabriel Hernandez , et al Added: 5 months ago

Imaging & Diagnostics

Heart Failure
Author(s): Finn Gustafsson Added: 1 year ago
HFA 24 - Dr Finn Gustafsson (Rigshospitalet, DK) joined us onsite at the Heart Failure Association Congress to discuss the findings from a subanalysis of the ARIES HeartMate 3 study (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were treated with two… View more

Anticoagulation

Heart Failure
View from the Thoraxcenter: ESC Congress 25 Preview
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 8 months ago
Expert interventionalists, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) discuss the most anticipated hot line studies to be unveiled at ESC Congress 2025. Tune in for their in-depth analysis to get ahead of the curve.ESC Congress 2025 Hot Line Trials Discussed:00:25 DOUBLE-CHOICE03:03 VANTAGE05:03 VICTOR06:28 VICTORIA07:58 DIGIT HF10:19 DAPA ACT HF-TIMI… View more

Intervention

Prevention & Chronic Conditions
ESC 25: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 7 months ago
ESC Congress 2025 - The opening day of ESC Congress 2025 delivered compelling new developments as updated clinical practice guidelines were released alongside a series of eagerly awaited Hot Line trials.Leading interventional cardiologists, Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) present focused overviews of the most significant Hot Line and Late… View more

Intervention

Guidelines & Statements
Frailty in Cardio-oncology
Author(s): Ilaria Torre , Lorenzo Tinti , Ludovica Amore , et al Added: 2 months ago

CV Disease in Special Populations

Heart Failure
HFpEF-ABA Score Outperforms NT-proBNP in Trial Enrichment
Added: 4 months ago Source:  Radcliffe Cardiology
A new post hoc analysis of the SUMMIT trial suggests the HFpEF-ABA score is a more effective and inclusive enrichment tool than natriuretic peptide (NP) levels for clinical trials in patients with obesity-related heart failure with preserved ejection fraction (HFpEF).¹ The findings indicate the score, which is based on age, body mass index (BMI), and history of atrial fibrillation (AF), can… View more

Imaging & Diagnostics

Cardiovascular Renal Metabolic
View from the Thoraxcenter: What's Hot at ACC.25?
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 1 year ago
Join renowned interventional cardiologists Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) for an exclusive preview of ACC.25's most significant late-breaking science.This episode of View from the Thoraxcenter delivers authoritative analysis of pivotal cardiovascular trials set to revolutionize clinical practice and research. Elevate your conference… View more

Intervention

Heart Failure
Late breaking Clinical Trial Data Addressing Cardiovascular Outcomes in Patients with Diabetes presented at American College of Cardiology Congress
Added: 2 years ago Source:  Radcliffe Cardiology
AUTHOR: Greg GuilloryTwo late-breaking clinical trials addressing cardiovascular outcomes in patients with diabetes were presented this week at the American College of Cardiology meeting in Atlanta, USA. One of these trials looked at the effects of the hyperactivation of the polyol pathway on diabetic cardiomyopathy (DbCM) and the other the effects of chelation therapy in patients with diabetes… View more

Cardiovascular Renal Metabolic

Heart Failure
Development of Small-molecule SERCA Stimulators
Author(s): Antonio Zaza , Marcella Rocchetti Added: 9 months ago

Heart Failure